Corcept (CORT) Falls on Loss of Korlym Patent Lawsuit to Teva
https://www.zacks.com/stock/news/2204522/corcept-cort-falls-on-loss-of-korlym-patent-lawsuit-to-teva?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2204522
Jan 02, 2024 - The United States district court for the district of New Jersey rules against Corcept (CORT) in a patent infringement lawsuit against Teva Pharmaceuticals. Stock declines.
0
Corcept Therapeutics plunges after loss in patent battle with with Teva
https://seekingalpha.com/news/4051439-corcept-therapeutics-plunges-after-loss-in-patent-battle-with-with-teva?source=feed_sector_healthcare
Jan 01, 2024 - Corcept Therapeutics (CORT) tumbles 38% in after-hours trading following a patent trial loss to Teva (TEVA) over its Cushing's syndrome drug, Korlym.
0
Teva: 4 Key Drivers For A 2024 Revival (Upgraded Rating)
https://seekingalpha.com/article/4656759-teva-4-key-drivers-for-a-2024-revival-upgraded-rating?source=feed_tag_israel
Dec 07, 2023 - Teva Pharmaceutical has a disciplined financial management and innovative product pipeline. Find out why TEVA stock is a Buy.
0
Teva analysis shows migraine drug as effective in obese patients as non-obese
https://seekingalpha.com/news/4044016-teva-analysis-shows-migraine-drug-as-effective-in-obese-patients-as-non-obese?source=feed_sector_healthcare
Dec 06, 2023 - Teva Pharmaceutical Industries (TEVA) said that its drug Ajovy was found to be as effective in reducing migraine attacks in obese patients as non-obese. Read more here.
0
Teva Pharmaceutical Industries Limited (TEVA) Presents at 6th Annual Evercore ISI HealthCONx Conference (Transcript)
https://seekingalpha.com/article/4654636-teva-pharmaceutical-industries-limited-teva-presents-6th-annual-evercore-isi-healthconx?source=feed_tag_israel
Nov 28, 2023 -
0